Absci Corporation (ABSI)
NASDAQ$3.065-0.15 (-4.67%)
Market Cap
$368.69M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
413 of 924
Rank in Industry
241 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
ABSI Insider Trading Activity
ABSI Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $13,738,892 | 2 | 100 |
Related Transactions
| Jonasson Zachariah | CFO / CBO | 0 | $0 | 1 | $98,892 | $-98,892 |
| Phoenix Venture Partners II LP | 10 percent owner | 0 | $0 | 1 | $13.64M | $-13.64M |
About Absci Corporation
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Insider Activity of Absci Corporation
Over the last 12 months, insiders at Absci Corporation have bought $0 and sold $13.74M worth of Absci Corporation stock.
On average, over the past 5 years, insiders at Absci Corporation have bought $40.83M and sold $13.74M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 222,222 shares for transaction amount of $999,999 was made by Redmile Group, LLC (director) on 2024‑03‑01.
List of Insider Buy and Sell Transactions, Absci Corporation
| 2024-06-13 | Sale | Jonasson Zachariah | CFO / CBO | 19,859 0.0194% | $4.98 | $98,892 | -12.13% | |
| 2024-05-22 | Sale | Phoenix Venture Partners II LP | 10 percent owner | 3.1M 2.6164% | $4.40 | $13.64M | -15.18% | |
| 2024-03-01 | Redmile Group, LLC | director | 222,222 0.1982% | $4.50 | $999,999 | -24.91% | ||
| 2022-02-09 | Korman Sarah | General Counsel | 4,250 0.0044% | $7.96 | $33,830 | -59.91% | ||
| 2022-01-20 | Bedrick Todd | VP, CCPAO | 2,000 0.0023% | $7.50 | $15,000 | -50.42% | ||
| 2022-01-19 | McClain Sean | President and Chief Executive | 7,155 0.0081% | $6.92 | $49,513 | -47.79% | ||
| 2021-07-26 | Redmile Group, LLC | director | 1.88M 1.7426% | $16.00 | $30M | -63.43% | ||
| 2021-07-26 | Casdin Partners Master Fund, L.P. | director | 1.56M 1.4521% | $16.00 | $25M | -63.43% | ||
| 2021-07-26 | Casdin Eli | director | 1.56M 1.4521% | $16.00 | $25M | -63.43% | ||
| 2021-07-26 | McClain Sean | President and Chief Executive | 600 0.0006% | $16.00 | $9,600 | -63.43% | ||
| 2021-07-26 | MCGINNIS KAREN K | director | 15,000 0.0139% | $16.00 | $240,000 | -63.43% | ||
| 2021-07-26 | Korman Sarah | General Counsel | 10,000 0.0093% | $16.00 | $160,000 | -63.43% | ||
| 2021-07-26 | Jonasson Zachariah | director | 9,000 0.0084% | $16.00 | $144,000 | -63.43% | ||
| 2021-07-26 | Bedrick Todd | VP, CCPAO | 1,000 0.0009% | $16.00 | $16,000 | -63.43% |
Total: 14
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| Jonasson Zachariah | CFO / CBO | 384751 0.335% | $1.24M | 1 | 1 | <0.0001% |
| Redmile Group, LLC | director | 8253316 7.1858% | $26.49M | 2 | 0 | <0.0001% |
| Casdin Eli | director | 6745333 5.8729% | $21.65M | 1 | 0 | <0.0001% |
| Casdin Partners Master Fund, L.P. | director | 6745333 5.8729% | $21.65M | 1 | 0 | <0.0001% |
| McClain Sean | President and Chief Executive | 6368955 5.5452% | $20.44M | 2 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$5,911,307 | 70 | -1.38% | $321.78M | |
$84,871,118 | 57 | 17.71% | $376.76M | |
$109,415,500 | 33 | 18.13% | $364.07M | |
$41,446,394 | 27 | 12.91% | $324.97M | |
$14,865,077 | 18 | -28.56% | $392.72M |
ABSI Institutional Investors: Active Positions
| Increased Positions | 81 | +61.83% | 10M | +13.61% |
| Decreased Positions | 54 | -41.22% | 8M | -10.78% |
| New Positions | 37 | New | 3M | New |
| Sold Out Positions | 24 | Sold Out | 3M | Sold Out |
| Total Postitions | 158 | +20.61% | 75M | +2.84% |
ABSI Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Fmr Llc | $42,431.00 | 11.75% | 13.51M | +785,185 | +6.17% | 2024-12-31 |
| Ark Investment Management Llc | $25,955.00 | 7.19% | 8.27M | +2M | +30.43% | 2024-12-31 |
| Redmile Group, Llc | $25,915.00 | 7.18% | 8.25M | 0 | 0% | 2024-12-31 |
| Fred Alger Management, Llc | $20,427.00 | 5.66% | 6.51M | -1M | -14.03% | 2024-12-31 |
| Blackrock, Inc. | $20,202.00 | 5.6% | 6.43M | +655,062 | +11.34% | 2024-12-31 |
| Vanguard Group Inc | $14,991.00 | 4.15% | 4.77M | -169,271 | -3.42% | 2024-12-31 |
| Ameriprise Financial Inc | $8,152.00 | 2.26% | 2.6M | -23,668 | -0.9% | 2024-12-31 |
| State Street Corp | $6,334.00 | 1.75% | 2.02M | +88,512 | +4.59% | 2024-12-31 |
| Geode Capital Management, Llc | $6,122.00 | 1.7% | 1.95M | +16,217 | +0.84% | 2024-12-31 |
| Marshall Wace, Llp | $3,617.00 | 1% | 1.15M | -152,915 | -11.72% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.